gms | German Medical Science

Deutscher Kongress für Orthopädie und Unfallchirurgie (DKOU 2021)

26. - 29.10.2021, Berlin

Development of antibiotic resistance in periprosthetic joint infection after total knee arthroplasty

Meeting Abstract

Suche in Medline nach

  • presenting/speaker Antonio Klasan - Kepler Universitätsklinikum GmbH, Med Campus III, Universitätsklinik für Orthopädie und Traumatologie, Linz, Austria
  • Susanne Fuchs-Winkelmann - Universitätsklinikum Gießen und Marburg, Standort Marburg, Klinik für Orthopädie und Rheumatologie, Marburg, Germany
  • Thomas J. Heyse - OrthoMEDIC Gelenkzentrum, Frankfurt Offenbach, Offenbach, Germany

Deutscher Kongress für Orthopädie und Unfallchirurgie (DKOU 2021). Berlin, 26.-29.10.2021. Düsseldorf: German Medical Science GMS Publishing House; 2021. DocAB50-34

doi: 10.3205/21dkou274, urn:nbn:de:0183-21dkou2749

Veröffentlicht: 26. Oktober 2021

© 2021 Klasan et al.
Dieser Artikel ist ein Open-Access-Artikel und steht unter den Lizenzbedingungen der Creative Commons Attribution 4.0 License (Namensnennung). Lizenz-Angaben siehe http://creativecommons.org/licenses/by/4.0/.


Gliederung

Text

Objectives: Management of periprosthetic joint infection (PJI) after total knee arthroplasty (TKA) is challenging. Antibiotic management remains elusive due to differences in epidemiology and resistance between countries and reports. Before the efficacy of surgical treatment options is investigated, it is crucial to investigate the bacterial strains causing PJI, especially for cases where a culture could not be obtained.

Methods: A review of all revision TKAs between 2006 and 2018 in a tertiary referral center was performed. Included were cases meeting the consensus criteria for PJI, with identified cultures. Using a cluster analysis, 3 chronological time periods were created. We then evaluated antibiotic resistance of identified bacteria between these 3 clusters and the effectiveness of our antibiotic regime.

Results and Conclusion: We identified 129 PJI with 161 culture identified bacteria. Coagulase-negative Staphylococci (CNS) were diagnosed in 46.6% cultures, followed by Staphylococcus aureus in 19.8% of cultures. Overall antibiotic resistance (p=0.454) has not increased during the study period. CNS resistance to teicoplanin (p<0.001), fosfomycin (p=0.016) and tetracycline (p=0.014) has increased. Vancomycin had an 84.4% overall sensitivity and 100% CNS sensitivity and was the most effective agent. Although we were unable to show an overall increase in antibiotic resistance in organisms that cause PJI after TKA during the study period, this was not true for CNS. It is concerning to note that when specifically looking at CNS resistance to new antibiotics, but not vancomycin, it has increased in little more than a decade. This study suggests that referral centres should continuously monitor obtained cultures as this has significant implications for both prophylactic treatment in primary as well as empirical antibiotic treatment in PJI.